• Skip to content
  • Skip to navigation
  • Skip to footer
AstraZeneca logo AstraZeneca logo
AstraZeneca logo AstraZeneca logo
  • What science can do
    What science can do
    • Stories of impact
    • Publications
  • R&D
    R&D
    • Our approach
      Our approach to R&D
      • STEM at AstraZeneca
    • Precision medicine
    • Transformative science
    • Data science & AI
    • Clinical innovation
    • Our technologies
    • Next generation therapeutics
    • R&D strategic centres
    Featured website AstraZeneca Clinical Trials Clinical trial website thumbnail Featured website Open Innovation OpenInnovation logo
  • Our therapy areas
    Our therapy areas
    • Oncology
    • BioPharmaceuticals
    • Cardiovascular, Renal and Metabolism
    • Respiratory & Immunology
    • Vaccines and Immune Therapies
    • Rare Disease
    • Pipeline
    • All medicines
  • Our company
    Our company
    • Our history
    • Our people
      Our people
      • Oncology
      • BioPharmaceuticals
      • Rare Disease
      • Research & Development
      • Enabling functions
      • Operations
      • International
    • Our leadership
    • Cambridge
    • Gothenburg
    • Gaithersburg
  • Careers
    Careers
    • Great place to work
    • Inclusion and diversity
    • Learning and development
    • Employee resource groups
  • Investors
    Investor Relations (Global)
    • Investor Relations (Sweden)
    • Resources
    • Governance
    • Shareholder information
    • Dividend policy
    • Key facts
    • FAQs
    • Debt Investors
    • ADR Programme
    • Annual Report 2024
    Feature Full Year and Q4 2024 results silhouette signature image Feature Results and presentations ipad image
  • Media
    Media
    • Press Releases
    • Articles
    • Image library
    • Archive
    • Media contacts
    • Investor Day 2024
  • Sustainability
    Sustainability
    • Access to healthcare
      Overview Access to healthcare
      • Equitable access
      • Affordability and pricing
      • Health system resilience
    • Environmental protection
      Overview Environmental protection
      • Ambition Zero Carbon
      • Product sustainability
      • Natural resources
    • Ethics and transparency
      Overview Ethics and transparency
      • Ethical business culture
      • Inclusion and diversity
      • Workforce safety and health
    • Partnerships, alliances and recognition
    • Supporting our communities
    • Resources
      Sustainability reports and resources
      • Our sustainability impact
      • Sustainable Procurement
    Feature Our sustainability impact
  • Partnering
    Partnering
    • Our business development teams
    • Our areas of partnering interest
    • Why partner with AstraZeneca?
    • Information for Suppliers
    • Supplier Sustainability Hub
    • A Catalyst Network
  • AstraZeneca Websites
  • Global site

Site map

View global sites

View resources

What science can do

Disease understanding
Next generation therapeutics
Predicting clinical success
Clinical innovation
Technologies
Data science & AI
Sustainability
COVID-19

R&D

Our approach to R&D
Transformative science
Data Science & Artificial Intelligence
Our technologies
Next generation therapeutics
Publications
Our strategic R&D centres

Our therapy areas

Oncology
BioPharmaceuticals
Cardiovascular, Renal and Metabolism
Respiratory & Immunology
Vaccines and Immune Therapies
Rare disease
Neuroscience
Our pipeline
All medicines

Our company

Our people
Our leadership team
AstraZeneca in Cambridge
AstraZeneca in Gothenburg
AstraZeneca in Gaithersburg


Careers

Global careers site

Investor Relations

Stock Exchange announcements
Results and presentations
Annual Reports
Governance
Dividend policy
Debt Investors
ADR Programme
Shareholder information
Key facts
FAQs


Media centre

Image library
Articles
Press Releases
Archive
Medical Releases

Sustainability

Access to healthcare
Environmental protection
Ethics and transpartency
Resources


Partnering

Our Partnering teams
Our areas of partnering interest
Why partner with AstraZeneca?
Supplier information
A.Catalyst Network

AstraZeneca Websites

This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network.


Veeva ID: Z4-68564
Date of next review: August 2026

Resources

  • All resources
  • Open Innovation
  • Externally sponsored scientific research
  • Medical Information for HCPs
  • US prescription assistance programmes
  • Global clinical trials information
  • Medicines
  • Report a possible side effect

Quick links

  • Media
  • Investor Relations
  • Partnering
  • Careers
  • Sustainability
  • Modern Slavery Statement
  • AZethics – Report A Concern
  • Supplier information
  • Social Media Community Guidelines

Social Media

  • Linkedn
  • Instagram
  • Facebook
  • Twitter
  • YouTube
  • Glassdoor

utility links

  • Legal notice and Terms of Use
  • Privacy notice
  • Site map
  • Contact us
  • Cookie preferences

© AstraZeneca 2025

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree